Analyst firms · Argus Research · MNST
Argus Research MNST price target and rating history
Monster Beverage Corporation (MNST) · Consumer Staples
Argus Research rates Monster Beverage Corporation (MNST) Buy with a $100 price target, as of its latest action on Mar 3, 2026. It has published 3 rating actions on MNST since November 2024, including 0 upgrades and 0 downgrades. Across 18 firms with a MNST price target in the last 12 months, the median target is $99. Argus Research's $100 is 1% above that.
- Current rating
- Buy
- Price target
- $100
- Median target, all firms
- $99
- Actions on MNST
- 3
Argus Research price target on MNST
Every Argus Research rating on MNST
- Mar 3, 2026
- Jan 27, 2026
- Nov 12, 2024
How other firms rate MNST
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | $105 | Aug 7, 2026 |
| RBC Capital Markets | Outperform | $100 | Aug 7, 2026 |
| Evercore ISI | Outperform | $105 | Aug 7, 2026 |
| Deutsche Bank | Hold | $98 | Jul 20, 2026 |
| Stifel | Buy | $105 | Jul 16, 2026 |
| Citigroup | Buy | $113 | Jul 14, 2026 |
| TD Cowen | Hold | $95 | Jul 8, 2026 |
| Wells Fargo | Overweight | $105 | Jul 8, 2026 |
| Bernstein | Mkt Perform | $95 | Jun 12, 2026 |
| Morgan Stanley | Overweight | $103 | Jun 1, 2026 |
| Rothschild & Co Redburn | Buy | $90 | May 6, 2026 |
| BofA Securities | Buy | $96 | Apr 10, 2026 |
| Argus Research | Buy | $100 | Mar 3, 2026 |
| Jefferies | Buy | $100 | Feb 27, 2026 |
| Piper Sandler | Overweight | $94 | Feb 27, 2026 |
| BNP Paribas Exane | Neutral | $77 | Jan 16, 2026 |
| Goldman Sachs | Buy | $83 | Dec 3, 2025 |
| BMO Capital Markets | Market Perform | $73 | Dec 3, 2025 |
Questions about Argus Research and MNST
- What is Argus Research's price target for MNST?
- Argus Research's latest stated price target for Monster Beverage Corporation (MNST) is $100, from its action on Mar 3, 2026.
- What is Argus Research's rating on MNST?
- Argus Research rates MNST Buy, a bullish rating, as of Mar 3, 2026.
- When did Argus Research last change its view on MNST?
- On Mar 3, 2026, Argus Research raises its price target to $100 from $95, keeps Buy.
- How does Argus Research's MNST target compare with other analysts?
- Across 18 firms with a MNST price target in the last 12 months, the median target is $99. Argus Research's $100 is 1% above that.
More MNST rating histories
- UBS21
- RBC Capital Markets12
- Evercore ISI7
- Deutsche Bank15
- Stifel9
- Citigroup14
- TD Cowen8
- Wells Fargo22
- Morgan Stanley15
- Rothschild & Co Redburn5
- BofA Securities8
- Jefferies6
- Piper Sandler12
- BNP Paribas Exane3
- Goldman Sachs5
- BMO Capital Markets7
- Roth Capital7
- Truist Securities5
- J.P. Morgan11
All Argus Research ratingsMNST news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.